BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25497450)

  • 1. The Great Recession, insurance mandates, and the use of in vitro fertilization services in the United States.
    Kiatpongsan S; Huckman RS; Hornstein MD
    Fertil Steril; 2015 Feb; 103(2):448-54. PubMed ID: 25497450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracytoplasmic sperm injection use in states with and without insurance coverage mandates for infertility treatment, United States, 2000-2015.
    Dieke AC; Mehta A; Kissin DM; Nangia AK; Warner L; Boulet SL
    Fertil Steril; 2018 Apr; 109(4):691-697. PubMed ID: 29580644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro fertilization availability and utilization in the United States: a study of demographic, social, and economic factors.
    Hammoud AO; Gibson M; Stanford J; White G; Carrell DT; Peterson M
    Fertil Steril; 2009 May; 91(5):1630-5. PubMed ID: 18539275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insurance mandates and trends in infertility treatments.
    Henne MB; Bundorf MK
    Fertil Steril; 2008 Jan; 89(1):66-73. PubMed ID: 17482603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insurance coverage and outcomes of in vitro fertilization.
    Jain T; Harlow BL; Hornstein MD
    N Engl J Med; 2002 Aug; 347(9):661-6. PubMed ID: 12200554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Building a family through in vitro fertilization--economic realities.
    Devine K; Stillman RJ; DeCherney AH
    Fertil Steril; 2015 Feb; 103(2):357-8. PubMed ID: 25527233
    [No Abstract]   [Full Text] [Related]  

  • 7. Impact of in vitro fertilization state mandates for third party insurance coverage in the United States: a review and critical assessment.
    Peipert BJ; Montoya MN; Bedrick BS; Seifer DB; Jain T
    Reprod Biol Endocrinol; 2022 Aug; 20(1):111. PubMed ID: 35927756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National trends in health insurance coverage of pregnant and reproductive-age women, 2000 to 2009.
    Kozhimannil KB; Abraham JM; Virnig BA
    Womens Health Issues; 2012 Mar; 22(2):e135-41. PubMed ID: 22385900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Economic implications of insurance coverage for in vitro fertilization in the United States. A review.
    Omurtag KR; Styer AK; Session D; Toth TL
    J Reprod Med; 2009; 54(11-12):661-8. PubMed ID: 20120898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assisted reproductive technology surveillance--United States, 2011.
    Sunderam S; Kissin DM; Crawford SB; Folger SG; Jamieson DJ; Barfield WD;
    MMWR Surveill Summ; 2014 Nov; 63(10):1-28. PubMed ID: 25412164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unmet financial burden of infertility care and the impact of state insurance mandates in the United States: analysis from a popular crowdfunding platform.
    Lai JD; Fantus RJ; Cohen AJ; Wan V; Hudnall MT; Pham M; Brannigan RE; Halpern JA
    Fertil Steril; 2021 Oct; 116(4):1119-1125. PubMed ID: 34246467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expensive but worth it: older parents' attitudes and opinions about the costs and insurance coverage for in vitro fertilization.
    Nachtigall RD; MacDougall K; Davis AC; Beyene Y
    Fertil Steril; 2012 Jan; 97(1):82-7. PubMed ID: 22118993
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assisted reproductive technology surveillance -- United States, 2010.
    Sunderam S; Kissin DM; Crawford S; Anderson JE; Folger SG; Jamieson DJ; Barfield WD;
    MMWR Surveill Summ; 2013 Dec; 62(9):1-24. PubMed ID: 24304902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with early in vitro fertilization treatment discontinuation.
    Bedrick BS; Anderson K; Broughton DE; Hamilton B; Jungheim ES
    Fertil Steril; 2019 Jul; 112(1):105-111. PubMed ID: 31043233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 2007-09 recession and health insurance coverage.
    Holahan J
    Health Aff (Millwood); 2011 Jan; 30(1):145-52. PubMed ID: 21134911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of insurance mandates on choices and outcomes in infertility treatment markets.
    Hamilton BH; McManus B
    Health Econ; 2012 Aug; 21(8):994-1016. PubMed ID: 21905150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assisted reproductive technology surveillance--United States, 2009.
    Sunderam S; Kissin DM; Flowers L; Anderson JE; Folger SG; Jamieson DJ; Barfield WD;
    MMWR Surveill Summ; 2012 Nov; 61(7):1-23. PubMed ID: 23114281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. State-mandated insurance coverage is associated with the approach to hydrosalpinges before IVF.
    Omurtag K; Grindler NM; Roehl KA; Bates GW; Beltsos AN; Odem RR; Jungheim ES
    Reprod Biomed Online; 2014 Jul; 29(1):131-5. PubMed ID: 24813751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State-Mandated Insurance Coverage and Preimplantation Genetic Testing in the United States.
    Bedrick BS; Tipping AD; Nickel KB; Riley JK; Jain T; Jungheim ES
    Obstet Gynecol; 2022 Apr; 139(4):500-508. PubMed ID: 35271533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in the use of intracytoplasmic sperm injection in the United States.
    Jain T; Gupta RS
    N Engl J Med; 2007 Jul; 357(3):251-7. PubMed ID: 17634460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.